Stoneridge Investment Partners LLC decreased its holdings in shares of Aetna Inc (NYSE:AET) by 8.0% during the 4th quarter, Holdings Channel reports. The firm owned 34,113 shares of the company’s stock after selling 2,977 shares during the period. Stoneridge Investment Partners LLC’s holdings in Aetna were worth $6,154,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Janus Henderson Group PLC increased its stake in shares of Aetna by 1.8% during the 3rd quarter. Janus Henderson Group PLC now owns 4,407,172 shares of the company’s stock worth $700,784,000 after purchasing an additional 78,272 shares during the last quarter. Neuberger Berman Group LLC increased its stake in shares of Aetna by 5.9% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,487,570 shares of the company’s stock worth $236,538,000 after purchasing an additional 82,540 shares during the last quarter. Orbimed Advisors LLC increased its stake in shares of Aetna by 57.3% during the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after purchasing an additional 508,600 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of Aetna by 4.2% during the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock worth $217,144,000 after purchasing an additional 54,928 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its stake in shares of Aetna by 2.6% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 1,235,475 shares of the company’s stock worth $222,868,000 after purchasing an additional 30,799 shares during the last quarter. Institutional investors own 87.41% of the company’s stock.

Aetna Inc (AET) opened at $180.01 on Tuesday. Aetna Inc has a 12 month low of $119.51 and a 12 month high of $194.40. The company has a quick ratio of 0.53, a current ratio of 1.68 and a debt-to-equity ratio of 0.52. The stock has a market cap of $60,458.00, a price-to-earnings ratio of 31.47, a P/E/G ratio of 1.50 and a beta of 0.60.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The business had revenue of $14.74 billion for the quarter, compared to analyst estimates of $14.79 billion. During the same period last year, the business posted $0.08 EPS. Aetna’s revenue was down 6.2% compared to the same quarter last year. equities analysts anticipate that Aetna Inc will post 10.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.11%. Aetna’s payout ratio is presently 34.78%.

Several research analysts have recently commented on the stock. Citigroup lowered shares of Aetna from a “buy” rating to a “neutral” rating and increased their price target for the stock from $187.89 to $212.00 in a research note on Wednesday, January 31st. Piper Jaffray Companies restated a “buy” rating and set a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research note on Friday. Credit Suisse Group increased their price target on shares of Aetna from $200.00 to $208.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 31st. Finally, Cowen restated a “buy” rating and set a $212.00 price target on shares of Aetna in a research note on Tuesday, January 30th. Ten equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $185.94.

ILLEGAL ACTIVITY WARNING: “Aetna Inc (AET) Shares Sold by Stoneridge Investment Partners LLC” was published by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark law. The original version of this story can be accessed at https://www.dailypolitical.com/2018/02/06/aetna-inc-aet-shares-sold-by-stoneridge-investment-partners-llc.html.

Aetna Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.